Literature DB >> 21526904

Clinical and virological features of enterovirus 71 infections in Denmark, 2005 to 2008.

Shadia Ali Badran1, Sofie Midgley, Peter Andersen, Blenda Böttiger.   

Abstract

BACKGROUND: Since the late 1990s enterovirus 71 (EV71) has caused epidemics of hand, foot and mouth disease with fatal cases especially in the Asian Pacific region. The objective of this study was to describe the clinical and virological features of EV71 infections in Denmark.
METHODS: All enterovirus-positive samples in Denmark are submitted to the National Poliovirus Laboratory for typing, and the EV71-positive samples are characterized by sequencing and phylogenetic analysis. Clinical information was gathered for the EV71-positive patients.
RESULTS: During 2005-2008, EV71 was demonstrated in 29 patients. In 2007 EV71 was the second most common enterovirus type detected in Denmark. Twenty-one of the 29 patients were children aged ≤1 y, 24 were hospitalized, and meningitis was the most common diagnosis. Gastroenteritis and hand, foot and mouth disease were other common clinical manifestations, but no fatal cases or cases of pulmonary oedema were seen. A novel subgenotype in Europe, B5, dominated the 2007 outbreak, but co-circulated with subgenotypes C1 and C2.
CONCLUSIONS: In conclusion EV71 was among the common enterovirus types in Denmark, and in 2007 a novel subgenotype, B5, was observed. EV71 was mainly diagnosed in infants, and the majority of patients were hospitalized with meningitis.

Entities:  

Mesh:

Year:  2011        PMID: 21526904     DOI: 10.3109/00365548.2011.577094

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  10 in total

1.  Emerging and reemerging neurologic infections.

Authors:  Felicia C Chow; Carol A Glaser
Journal:  Neurohospitalist       Date:  2014-10

2.  The Pathogenesis and Prevention of Encephalitis due to Human Enterovirus 71.

Authors:  Emily Jane Bek; Peter Charles McMinn
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

3.  Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications.

Authors:  Wei Xu; Chun-feng Liu; Li Yan; Jiu-jun Li; Li-jie Wang; Ying Qi; Rui-bo Cheng; Xiao-yu Xiong
Journal:  Virol J       Date:  2012-01-09       Impact factor: 4.099

Review 4.  Human enterovirus 71 epidemics: what's next?

Authors:  Cyril C Y Yip; Susanna K P Lau; Patrick C Y Woo; Kwok-Yung Yuen
Journal:  Emerg Health Threats J       Date:  2013-09-10

5.  Spatio-temporal analysis on enterovirus cases through integrated surveillance in Taiwan.

Authors:  Ta-Chien Chan; Jing-Shiang Hwang; Rung-Hung Chen; Chwan-Chuen King; Po-Huang Chiang
Journal:  BMC Public Health       Date:  2014-01-08       Impact factor: 3.295

6.  Enterovirus A71 subgenotype B5, France, 2013.

Authors:  Audrey Mirand; Lucie Molet; Chervin Hassel; Ha C lA Ne Peigue-Lafeuille; Flore Rozenberg; Jean-Luc Bailly; Ca C Cile Henquell
Journal:  Emerg Infect Dis       Date:  2015-04       Impact factor: 6.883

7.  Epidemiology and virologic investigation of human enterovirus 71 infection in the Republic of Korea from 2007 to 2012: a nationwide cross-sectional study.

Authors:  Hye-Jin Kim; Ji-Yeon Hyeon; Seoyeon Hwang; Yong-Pyo Lee; Sang Won Lee; Jung Sik Yoo; Byunghak Kang; Jeong-Bae Ahn; Yong-Seok Jeong; June-Woo Lee
Journal:  BMC Infect Dis       Date:  2016-08-18       Impact factor: 3.090

Review 8.  MicroRNA and Pathogenesis of Enterovirus Infection.

Authors:  Bing-Ching Ho; Pan-Chyr Yang; Sung-Liang Yu
Journal:  Viruses       Date:  2016-01-06       Impact factor: 5.048

9.  Epidemiology and seroepidemiology of human enterovirus 71 among Thai populations.

Authors:  Piyada Linsuwanon; Jiratchaya Puenpa; Sheng-Wen Huang; Ya-Fang Wang; John Mauleekoonphairoj; Jen-Ren Wang; Yong Poovorawan
Journal:  J Biomed Sci       Date:  2014-02-18       Impact factor: 8.410

10.  Inhibitory Effects of Norwogonin, Oroxylin A, and Mosloflavone on Enterovirus 71.

Authors:  Hwa Jung Choi; Hyuk-Hwan Song; Jae-Sug Lee; Hyun-Jeong Ko; Jae-Hyoung Song
Journal:  Biomol Ther (Seoul)       Date:  2016-09-01       Impact factor: 4.634

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.